相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The fifth cranial nerve in headaches
J. C. A. Edvinsson et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back
Chiara Demartini et al.
PROGRESS IN NEUROBIOLOGY (2019)
Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats
Kirk W. Johnson et al.
CEPHALALGIA (2019)
Primary headaches during lifespan
Andreas Straube et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Mechanisms of migraine as a chronic evolutive condition
Anna P. Andreou et al.
JOURNAL OF HEADACHE AND PAIN (2019)
CGRP/CGRP Receptor Antibodies: Potential Adverse Effects Due to Blockade of Neovascularization?
Masataka Majima et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
CGRP monoclonal antibody for preventive treatment of chronic migraine: An update of meta-analysis
Lin Han et al.
BRAIN AND BEHAVIOR (2019)
Prospective real-world analysis of OnabotulinumtoxinA in chronic migraine post-National Institute for Health and Care Excellence UK technology appraisal
A. P. Andreou et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Altered muscle activity during rest and during mental or physical activity is not a trait symptom of migraine - a neck muscle EMG study
Kerstin Luedtke et al.
JOURNAL OF HEADACHE AND PAIN (2018)
International Classification of Headache Disorders
Jes Olesen
LANCET NEUROLOGY (2018)
Emerging drugs for migraine treatment: an update
Giorgio Lambru et al.
EXPERT OPINION ON EMERGING DRUGS (2018)
Basic Considerations for the Use of Monoclonal Antibodies in Migraine
Morris Levin et al.
HEADACHE (2018)
Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody
Agustin Melo-Carrillo et al.
JOURNAL OF NEUROSCIENCE (2017)
Hypothalamus as a mediator of chronic migraine Evidence from high-resolution fMRI
Laura H. Schulte et al.
NEUROLOGY (2017)
A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience
Andrea Negro et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine
Christoph J. Schankin et al.
BRAIN (2016)
The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks
Laura H. Schulte et al.
BRAIN (2016)
Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
XiChun Zhang et al.
CEPHALALGIA (2016)
Nonparalytic botulinum molecules for the control of pain
Antonina S. Mangione et al.
PAIN (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Effects of peripheral FAAH blockade on NTG-induced hyperalgesiaevaluation of URB937 in an animal model of migraine
R. Greco et al.
CEPHALALGIA (2015)
Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents
Roshni Ramachandran et al.
NEUROBIOLOGY OF DISEASE (2015)
Modulation of nociceptive dural input to the trigeminocervical complex through Gluk1 kainate receptors
Anna P. Andreou et al.
PAIN (2015)
OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
Eva Cernuda-Morollon et al.
PAIN (2015)
Hunting for origins of migraine pain: cluster analysis of spontaneous and capsaicin-induced firing in meningeal trigeminal nerve fibers
A. Zakharov et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study
Andrea Negro et al.
SPRINGERPLUS (2015)
Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks
Farooq Husain Maniyar et al.
BRAIN (2014)
Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains
Rami Burstein et al.
CEPHALALGIA (2014)
CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine
Eva Cernuda-Morollon et al.
HEADACHE (2014)
Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
Modar Khalil et al.
JOURNAL OF HEADACHE AND PAIN (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
Eva Cernuda-Morollon et al.
NEUROLOGY (2013)
CORTICAL SPREADING DEPRESSION INDUCES OXIDATIVE STRESS IN THE TRIGEMINAL NOCICEPTIVE SYSTEM
A. Shatillo et al.
NEUROSCIENCE (2013)
Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study
Daniel Serrano et al.
VALUE IN HEALTH (2013)
CGRP and NO in the Trigeminal System: Mechanisms and Role in Headache Generation
Karl Messlinger et al.
HEADACHE (2012)
Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study
Dawn C. Buse et al.
HEADACHE (2012)
Photoreactivity of the Occipital Cortex Measured by Functional Magnetic Resonance Imaging-Blood Oxygenation Level Dependent in Migraine Patients and Healthy Volunteers: Pathophysiological Implications
Helena Martin et al.
HEADACHE (2011)
A Case Study for Calculating Employer Costs for Lost Productive Time in Episodic Migraine and Chronic Migraine Results of the American Migraine Prevalence and Prevention Study
Walter F. Stewart et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2011)
Risk of Development of Medication Overuse Headache With Nonsteroidal Anti-inflammatory Drug Therapy for Migraine A Critically Appraised Topic
Amaal J. Starling et al.
NEUROLOGIST (2011)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
S. K. Aurora et al.
CEPHALALGIA (2010)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
H. C. Diener et al.
CEPHALALGIA (2010)
Animal models of headache: from bedside to bench and back to bedside
Anna P. Andreou et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
David W. Dodick et al.
HEADACHE (2010)
Does sumatriptan cross the blood-brain barrier in animals and man?
Peer Carsten Tfelt-Hansen
JOURNAL OF HEADACHE AND PAIN (2010)
Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine prophylaxis
Parisa Gazerani et al.
PAIN (2010)
SNARE tagging allows stepwise assembly of a multimodular medicinal toxin
Frederic Darios et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Clostridial Neurotoxins: Mechanism of SNARE Cleavage and Outlook on Potential Substrate Specificity Reengineering
Thomas Binz et al.
TOXINS (2010)
Therapeutic potential of novel glutamate receptor antagonists in migraine
Anna P. Andreou et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Activation of TRPV1 Mediates Calcitonin Gene-Related Peptide Release, Which Excites Trigeminal Sensory Neurons and Is Attenuated by a Retargeted Botulinum Toxin with Anti-Nociceptive Potential
Jianghui Meng et al.
JOURNAL OF NEUROSCIENCE (2009)
Hypothalamic activation in spontaneous migraine attacks
Marie Denuelle et al.
HEADACHE (2007)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
Central sensitization theory of migraine: Clinical implications
David Dodick et al.
HEADACHE (2006)
Occipital activation in glyceryl trinitrate induced migraine with visual aura
S Afridi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
A positron emission tomographic study in spontaneous migraine
SK Afridi et al.
ARCHIVES OF NEUROLOGY (2005)
A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate
SK Afridi et al.
BRAIN (2005)
The orofacial formalin test
P Raboisson et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2004)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: Implications for migraine therapy
PL Durham et al.
HEADACHE (2004)
Effects of nimesulide on nitric oxide-induced hyperalgesia in humans - a neurophysiological study
G Sandrini et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Deconstructing migraine headache into peripheral and central sensitization
R Burstein
PAIN (2001)
分享论文
